Arguably, cardiac adrenergic signaling interacts with PDEs activity (levels of cAMP and cGMP in cardiomyocytes), but PDE5, in particular, may have a significant effect on diabetic cardiomyopathy, including reduced cardiac inotropy. The gene discussed is PDE5A; the disease is diabetic cardiomyopathy.